Voltage between electrodes in the chamber with lower concentration as a function of time for configurations A (black) and B (red) and for <i>C</i>_h/<i>C</i>_l... by Sławomir Grzegorczyn (12035398)

Projected annual CH₄ (A) and N₂O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a consta... by Fabio Correddu (12501799)

Probabilistic results of the incremental cost-effectiveness pairwise between various treatments with NVBP for a simulation of 100,000 iterations. by Yi Lin (49406)

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Cartilaginous extracellular matrix space was severely reduced in <i>Slc35a3</i>^{<i>–/–</i>}mice. by Soichiro Saito (15285875)

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Effects of GM-CSF on the DMN-induced inhibition of PPAR-γ expression. by Mrigendra Bir Karmacharya (13607415)

Effects of GM-CSF on DMN-induced TGF-β1 expression. by Mrigendra Bir Karmacharya (13607415)

Global number of meningitis deaths by etiology and age group in 1990(A) and 2021(B). by Jun Li (6494)

Nicotine decreased Wnt5a expressions in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1. by Rachel S. Resop (9238645)

Atherosclerosis is associated with a decrease in cerebral microvascular blood flow and tissue oxygenation by Baoqiang Li (1610221)

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

Decreased level of anandamide after different doses of PZQ treatment of <i>S</i>. <i>mekongi</i>. by Peerut Chienwichai (6521324)

The A1 mutation decreases antisense transcriptional activity of the LTR in OVK cells. by Thomas Joris (13224720)

Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”